Medy-Tox Inc (086900) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.041x

Based on the latest financial reports, Medy-Tox Inc (086900) has a cash flow conversion efficiency ratio of 0.041x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩19.03 Billion ≈ $12.90 Million USD) by net assets (₩467.65 Billion ≈ $316.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Medy-Tox Inc balance sheet quality to measure how much of total assets are equity-financed.

Medy-Tox Inc - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Medy-Tox Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 086900 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Medy-Tox Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medy-Tox Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Fiverr International Ltd NYSE:FVRR	0.050x
Spirox Corp TW:3055	-0.005x
Qingdao Richmat Intelligence Technology Co. Ltd. A SHE:301320	N/A
Ideal Group S.A AT:INTEK	-0.010x
Zhejiang Realsun Chemical Co. Ltd. SHE:301212	N/A
Hyulim ROBOT Co.Ltd KQ:090710	-0.070x
Exemplar REITail Ltd JSE:EXP	0.021x
Shenzhen Tongye Technology Co.Ltd. SHE:300960	-0.016x

Annual Cash Flow Conversion Efficiency for Medy-Tox Inc (2013–2024)

The table below shows the annual cash flow conversion efficiency of Medy-Tox Inc from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Medy-Tox Inc market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩470.78 Billion ≈ $319.04 Million	₩36.89 Billion ≈ $25.00 Million	0.078x	+174.98%
2023-12-31	₩474.48 Billion ≈ $321.55 Million	₩13.52 Billion ≈ $9.16 Million	0.028x	-53.44%
2022-12-31	₩428.04 Billion ≈ $290.08 Million	₩26.20 Billion ≈ $17.75 Million	0.061x	+22.47%
2021-12-31	₩399.48 Billion ≈ $270.72 Million	₩19.97 Billion ≈ $13.53 Million	0.050x	-56.80%
2020-12-31	₩241.40 Billion ≈ $163.59 Million	₩27.93 Billion ≈ $18.93 Million	0.116x	-11.05%
2019-12-31	₩259.15 Billion ≈ $175.62 Million	₩33.70 Billion ≈ $22.84 Million	0.130x	-40.35%
2018-12-31	₩252.59 Billion ≈ $171.17 Million	₩55.07 Billion ≈ $37.32 Million	0.218x	-26.10%
2017-12-31	₩191.65 Billion ≈ $129.88 Million	₩56.55 Billion ≈ $38.32 Million	0.295x	-19.46%
2016-12-31	₩147.68 Billion ≈ $100.08 Million	₩54.10 Billion ≈ $36.66 Million	0.366x	+85.86%
2015-12-31	₩113.48 Billion ≈ $76.91 Million	₩22.37 Billion ≈ $15.16 Million	0.197x	-84.74%
2014-12-31	₩81.59 Billion ≈ $55.29 Million	₩105.38 Billion ≈ $71.41 Million	1.292x	+372.27%
2013-12-31	₩60.68 Billion ≈ $41.13 Million	₩16.60 Billion ≈ $11.25 Million	0.273x	--

About Medy-Tox Inc

KQ:086900 Korea Biotechnology

Market Cap

$321.00 Million

₩473.67 Billion KRW

Market Cap Rank

#14326 Global

#429 in Korea

Share Price

₩72000.00

Change (1 day)

+1.69%

52-Week Range

₩68200.00 - ₩146600.00

All Time High

₩671543.08